White House warns about the harms of commercial marijuana
The wider administration has taken steps to profoundly normalize the drug and open the door to significant further commercialization.
Posts tagged “”
These are the “scientists” bringing you “safe and effective” medical marijuana
First it was Mehmet Oz, the guru of pseudoscience, who began giving an FDA-unapproved drug—CBD—to Medicare patients.
SAM Scores Big House Appropriations Win
Smart Approaches to Marijuana won some major victories for public health in the latest Congressional appropriations move.
President Trump has moved to reschedule marijuana. Now what?
What does this mean? And what do we do now?
Friday Fact: Intoxicating hemp exposures increased by 79% between 2021 and 2022
30% of those reports were of children 6 years old or under. But the end is in sight.
NEW POLL: Informed voters don’t want weed in Schedule III
When voters hear about the risks rescheduling brings, they get why it would be a terrible idea to put weed in Schedule III.
House hearing offers key insights into how legal weed helps China
The debate over rescheduling marijuana has brought one of the most underreported dangers of America’s weed trade into sharp focus: its penetration by Chinese criminal networks illegally growing marijuana throughout the country.
Kevin + SAMHSA on national marijuana trends and youth use
On Monday, Smart Approaches to Marijuana President and CEO Dr. Kevin Sabet spoke at a key event in fighting addiction: a webinar run by the Substance Abuse and Mental Health Services Administration (SAMHSA).
The FDA just brutally bodyslammed MDMA pharma company Lykos
The agency has made public the full letter it sent rejecting Lykos’ application to have its MDMA therapy approved as a drug . . . and it’s horrifying.